文献速递传染病防控与疫情报告免疫规划慢病防控与筛查

香港医院出院COVID-19幸存者中长期COVID及感染后疫苗接种加强剂的影响:一项回顾性观察研究

The impacts of long COVID and booster doses of post-infection vaccination among hospital-discharged COVID-19 survivors in Hong Kong: A retrospective observational study.
PubMed 文献 · Vaccine · 2025-11-27

该回顾性观察研究纳入香港一所大学教学医院717名COVID-19住院康复者,于2023年1月至2025年3月电话随访,分析长期COVID患病率、危险因素、疫苗接种状态及健康相关生活质量。长期COVID症状以气促、持续疲劳、健忘和持续干咳为主,接种至少三剂加强剂与这些症状的较低比值比相关。

要点

  • 长期COVID症状以气促(10.8%)、持续疲劳(9.8%)、健忘(9.5%)和持续干咳(4.3%)最常见。
  • 52.3%参与者在感染后接种三剂疫苗,其中71.3%接种BioNTech。
  • 接种加强剂(至少三剂)与气促、持续疲劳、健忘和持续干咳的较低比值比相关(均P<0.05)。

核心结论

  • 出院个体中长期COVID患病率较低,感染后疫苗接种加强剂可能降低出现这些症状的风险。
  • 需进一步研究长期COVID的潜在机制及如何减轻这些风险。

研究设计与样本

  • 回顾性观察研究,采用便利抽样从香港一所大学教学医院招募有COVID-19感染史的个体。
  • 1771名18岁及以上、COVID-19感染(经聚合酶链反应/快速抗原检测确认)且疫情期间住院的个体中,717人于2023年1月至2025年3月完成电话随访。
  • 分析长期COVID(按WHO定义)患病率、危险因素、疫苗接种状态和健康相关生活质量,比例按2023年香港成年人性别和年龄分布加权。

主要发现

  • 参与者平均年龄46.8岁(±17.4),67.4%为男性。
  • 最常见的长期COVID症状为气促(10.8%)、持续疲劳(9.8%)、健忘(9.5%)和持续干咳(4.3%)。
  • 52.3%参与者在感染COVID-19后接种三剂疫苗,其中71.3%接种BioNTech。
  • 经历气促、持续疲劳和健忘的参与者在EuroQol视觉模拟量表及VR-12生理和心理组分得分上较低,健康相关生活质量较差(均P<0.05)。
  • 接种加强剂(至少三剂)的参与者与气促、持续疲劳、健忘和持续干咳的较低比值比相关(均P<0.05)。

局限性

  • 需进一步研究以探讨长期COVID的潜在机制及如何减轻这些风险。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study examined the prevalence of long COVID, risk factors, vaccination status, and health-related quality of life in hospital-discharged individuals with a history of COVID-19 infection in Hong Kong. METHODS: This is a retrospective observational study. A convenience sampling was used to recruit individuals with a history of COVID-19 infection from a university teaching hospital in Hong Kong. 717 out of 1771 individuals aged 18 years or above with COVID-19 infection (confirmed by polymerase chain reaction/rapid antigen test) and hospitalized during the COVID-19 outbreak completed the telephone follow-up between January 2023 and March 2025. The prevalence of long COVID (defined by the WHO), risk factors, vaccination status, and health-related quality of life were analyzed. The proportions were weighted by the sex and age distribution of Hong Kong adults in 2023. RESULTS: The mean age of participants was 46.8 years (±17.4), and 67.4 % were men. The most prevalent long COVID symptoms were shortness of breath (10.8 %), persistent fatigue (9.8 %), forgetfulness (9.5 %), and persistent dry cough (4.3 %). 52.3 % of participants received three vaccine doses after contracting COVID-19, and 71.3 % of them received BioNTech. Participants who experienced shortness of breath, persistent fatigue, and forgetfulness had poorer health-related quality of life, as indicated by lower scores on the EuroQol-visual analog scales and the Physical and Mental Component Scores of the VR-12 (all P < 0.05). Participants who received booster doses (at least three doses) were associated with lower odds of experiencing long COVID symptoms, including shortness of breath, persistent fatigue, forgetfulness, and persistent dry cough (all P < 0.05). CONCLUSIONS: The prevalence of long COVID was low among the hospital-discharged individuals, and booster doses of post-infection vaccination might reduce the risk of experiencing these symptoms. Further investigation is needed to examine the underlying mechanisms of long COVID and how these risks can be mitigated.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Chau SL, Hung IFN, Luk TT, et al. The impacts of long COVID and booster doses of post-infection vaccination among hospital-discharged COVID-19 survivors in Hong Kong: A retrospective observational study. Vaccine. 2025. PMID: 41313894. doi:10.1016/j.vaccine.2025.128022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。